APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gabapentin Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gabapentin Drug Market Analysis and Forecast 2026-2032

20 December 2025215 pages

Choose your research edition.

Industry ResearchGabapentin Drug Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Gabapentin Drug Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Gabapentin Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gabapentin Drug Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Gabapentin Drug Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Gabapentin Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Gabapentin Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gabapentin Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gabapentin Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gabapentin Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Gabapentin Drug include Teva, Sun Pharmaceutical, Mylan, Pfizer, Zydus Pharmaceuticals, Tris Pharma, Taro, Sciegen Pharmaceuticals and Marksans Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Gabapentin Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gabapentin Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Gabapentin Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gabapentin Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gabapentin Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Gabapentin Drug sales, projected growth trends, production technology, application and end-user industry.

Gabapentin Drug Segment by Company

Teva

Sun Pharmaceutical

Mylan

Pfizer

Zydus Pharmaceuticals

Tris Pharma

Taro

Sciegen Pharmaceuticals

Marksans Pharma

Lupin Limited

Jiangsu Hengrui Medicine

InvaGen Pharmaceuticals

Hi-Tech Pharmaceuticals

Glenmark

Epic Pharma

Depomed

CSPC Ouyi Pharmaceutical

Aurobindo Pharma

Apotex

Amneal Pharmaceuticals

Alkem Laboratories

ACI HealthCare Limited

Acella Pharmaceuticals

Gabapentin Drug Segment by Type

Capsule

Oral Solution

Tablet

Gabapentin Drug Segment by Application

Postherpetic Neuralgia in Adults

Partial Onset Seizures

Others

Gabapentin Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gabapentin Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gabapentin Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gabapentin Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Gabapentin Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Gabapentin Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gabapentin Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gabapentin Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Capsule Major Manufacturers Table 3. Oral Solution Major Manufacturers Table 4. Tablet Major Manufacturers Table 5. Global Gabapentin Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Postherpetic Neuralgia in Adults Major Manufacturers Table 7. Partial Onset Seizures Major Manufacturers Table 8. Others Major Manufacturers Table 9. Gabapentin Drug Industry Trends Table 10. Gabapentin Drug Industry Drivers Table 11. Gabapentin Drug Industry Opportunities and Challenges Table 12. Gabapentin Drug Industry Restraints Table 13. Global Gabapentin Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Gabapentin Drug Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Gabapentin Drug Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Gabapentin Drug Revenue Market Share by Region (2021-2026) Table 17. Global Gabapentin Drug Revenue Market Share by Region (2027-2032) Table 18. Global Gabapentin Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 19. Global Gabapentin Drug Sales by Region (2021-2026) & (W Units) Table 20. Global Gabapentin Drug Sales by Region (2027-2032) & (W Units) Table 21. Global Gabapentin Drug Sales Market Share by Region (2021-2026) Table 22. Global Gabapentin Drug Sales Market Share by Region (2027-2032) Table 23. Global Gabapentin Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Gabapentin Drug Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Gabapentin Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Gabapentin Drug Sales Market Share by Manufacturers (2021-2026) Table 27. Global Gabapentin Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Gabapentin Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Gabapentin Drug Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Gabapentin Drug Manufacturers, Product Type & Application Table 31. Global Gabapentin Drug Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Gabapentin Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Gabapentin Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Gabapentin Drug Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Gabapentin Drug Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Gabapentin Drug Revenue Market Share by Type (2021-2026) Table 38. Global Gabapentin Drug Revenue Market Share by Type (2027-2032) Table 39. Global Gabapentin Drug Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 40. Global Gabapentin Drug Sales by Type (2021-2026) & (W Units) Table 41. Global Gabapentin Drug Sales by Type (2027-2032) & (W Units) Table 42. Global Gabapentin Drug Sales Market Share by Type (2021-2026) Table 43. Global Gabapentin Drug Sales Market Share by Type (2027-2032) Table 44. Global Gabapentin Drug Price by Type (2021-2026) & (US$/Unit) Table 45. Global Gabapentin Drug Price by Type (2027-2032) & (US$/Unit) Table 46. Global Gabapentin Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Gabapentin Drug Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Gabapentin Drug Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Gabapentin Drug Revenue Market Share by Application (2021-2026) Table 50. Global Gabapentin Drug Revenue Market Share by Application (2027-2032) Table 51. Global Gabapentin Drug Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 52. Global Gabapentin Drug Sales by Application (2021-2026) & (W Units) Table 53. Global Gabapentin Drug Sales by Application (2027-2032) & (W Units) Table 54. Global Gabapentin Drug Sales Market Share by Application (2021-2026) Table 55. Global Gabapentin Drug Sales Market Share by Application (2027-2032) Table 56. Global Gabapentin Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Gabapentin Drug Price by Application (2027-2032) & (US$/Unit) Table 58. Teva Company Information Table 59. Teva Business Overview Table 60. Teva Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Teva Gabapentin Drug Product Portfolio Table 62. Teva Recent Development Table 63. Sun Pharmaceutical Company Information Table 64. Sun Pharmaceutical Business Overview Table 65. Sun Pharmaceutical Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Sun Pharmaceutical Gabapentin Drug Product Portfolio Table 67. Sun Pharmaceutical Recent Development Table 68. Mylan Company Information Table 69. Mylan Business Overview Table 70. Mylan Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Mylan Gabapentin Drug Product Portfolio Table 72. Mylan Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Pfizer Gabapentin Drug Product Portfolio Table 77. Pfizer Recent Development Table 78. Zydus Pharmaceuticals Company Information Table 79. Zydus Pharmaceuticals Business Overview Table 80. Zydus Pharmaceuticals Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Zydus Pharmaceuticals Gabapentin Drug Product Portfolio Table 82. Zydus Pharmaceuticals Recent Development Table 83. Tris Pharma Company Information Table 84. Tris Pharma Business Overview Table 85. Tris Pharma Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Tris Pharma Gabapentin Drug Product Portfolio Table 87. Tris Pharma Recent Development Table 88. Taro Company Information Table 89. Taro Business Overview Table 90. Taro Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Taro Gabapentin Drug Product Portfolio Table 92. Taro Recent Development Table 93. Sciegen Pharmaceuticals Company Information Table 94. Sciegen Pharmaceuticals Business Overview Table 95. Sciegen Pharmaceuticals Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Sciegen Pharmaceuticals Gabapentin Drug Product Portfolio Table 97. Sciegen Pharmaceuticals Recent Development Table 98. Marksans Pharma Company Information Table 99. Marksans Pharma Business Overview Table 100. Marksans Pharma Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Marksans Pharma Gabapentin Drug Product Portfolio Table 102. Marksans Pharma Recent Development Table 103. Lupin Limited Company Information Table 104. Lupin Limited Business Overview Table 105. Lupin Limited Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Lupin Limited Gabapentin Drug Product Portfolio Table 107. Lupin Limited Recent Development Table 108. Jiangsu Hengrui Medicine Company Information Table 109. Jiangsu Hengrui Medicine Business Overview Table 110. Jiangsu Hengrui Medicine Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Jiangsu Hengrui Medicine Gabapentin Drug Product Portfolio Table 112. Jiangsu Hengrui Medicine Recent Development Table 113. InvaGen Pharmaceuticals Company Information Table 114. InvaGen Pharmaceuticals Business Overview Table 115. InvaGen Pharmaceuticals Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. InvaGen Pharmaceuticals Gabapentin Drug Product Portfolio Table 117. InvaGen Pharmaceuticals Recent Development Table 118. Hi-Tech Pharmaceuticals Company Information Table 119. Hi-Tech Pharmaceuticals Business Overview Table 120. Hi-Tech Pharmaceuticals Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Hi-Tech Pharmaceuticals Gabapentin Drug Product Portfolio Table 122. Hi-Tech Pharmaceuticals Recent Development Table 123. Glenmark Company Information Table 124. Glenmark Business Overview Table 125. Glenmark Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Glenmark Gabapentin Drug Product Portfolio Table 127. Glenmark Recent Development Table 128. Epic Pharma Company Information Table 129. Epic Pharma Business Overview Table 130. Epic Pharma Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Epic Pharma Gabapentin Drug Product Portfolio Table 132. Epic Pharma Recent Development Table 133. Depomed Company Information Table 134. Depomed Business Overview Table 135. Depomed Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Depomed Gabapentin Drug Product Portfolio Table 137. Depomed Recent Development Table 138. CSPC Ouyi Pharmaceutical Company Information Table 139. CSPC Ouyi Pharmaceutical Business Overview Table 140. CSPC Ouyi Pharmaceutical Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. CSPC Ouyi Pharmaceutical Gabapentin Drug Product Portfolio Table 142. CSPC Ouyi Pharmaceutical Recent Development Table 143. Aurobindo Pharma Company Information Table 144. Aurobindo Pharma Business Overview Table 145. Aurobindo Pharma Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Aurobindo Pharma Gabapentin Drug Product Portfolio Table 147. Aurobindo Pharma Recent Development Table 148. Apotex Company Information Table 149. Apotex Business Overview Table 150. Apotex Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Apotex Gabapentin Drug Product Portfolio Table 152. Apotex Recent Development Table 153. Amneal Pharmaceuticals Company Information Table 154. Amneal Pharmaceuticals Business Overview Table 155. Amneal Pharmaceuticals Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. Amneal Pharmaceuticals Gabapentin Drug Product Portfolio Table 157. Amneal Pharmaceuticals Recent Development Table 158. Alkem Laboratories Company Information Table 159. Alkem Laboratories Business Overview Table 160. Alkem Laboratories Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 161. Alkem Laboratories Gabapentin Drug Product Portfolio Table 162. Alkem Laboratories Recent Development Table 163. ACI HealthCare Limited Company Information Table 164. ACI HealthCare Limited Business Overview Table 165. ACI HealthCare Limited Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 166. ACI HealthCare Limited Gabapentin Drug Product Portfolio Table 167. ACI HealthCare Limited Recent Development Table 168. Acella Pharmaceuticals Company Information Table 169. Acella Pharmaceuticals Business Overview Table 170. Acella Pharmaceuticals Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 171. Acella Pharmaceuticals Gabapentin Drug Product Portfolio Table 172. Acella Pharmaceuticals Recent Development Table 173. North America Gabapentin Drug Revenue by Type (2021-2026) & (US$ Million) Table 174. North America Gabapentin Drug Revenue by Type (2027-2032) & (US$ Million) Table 175. North America Gabapentin Drug Sales by Type (2021-2026) & (W Units) Table 176. North America Gabapentin Drug Sales by Type (2027-2032) & (W Units) Table 177. North America Gabapentin Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 178. North America Gabapentin Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 179. North America Gabapentin Drug Revenue by Application (2021-2026) & (US$ Million) Table 180. North America Gabapentin Drug Revenue by Application (2027-2032) & (US$ Million) Table 181. North America Gabapentin Drug Sales by Application (2021-2026) & (W Units) Table 182. North America Gabapentin Drug Sales by Application (2027-2032) & (W Units) Table 183. North America Gabapentin Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 184. North America Gabapentin Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 185. North America Gabapentin Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. North America Gabapentin Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. North America Gabapentin Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. North America Gabapentin Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 189. North America Gabapentin Drug Sales by Country (2021-2026) & (W Units) Table 190. North America Gabapentin Drug Sales by Country (2027-2032) & (W Units) Table 191. North America Gabapentin Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 192. North America Gabapentin Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 193. United States Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 194. Canada Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 195. Europe Gabapentin Drug Revenue by Type (2021-2026) & (US$ Million) Table 196. Europe Gabapentin Drug Revenue by Type (2027-2032) & (US$ Million) Table 197. Europe Gabapentin Drug Sales by Type (2021-2026) & (W Units) Table 198. Europe Gabapentin Drug Sales by Type (2027-2032) & (W Units) Table 199. Europe Gabapentin Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 200. Europe Gabapentin Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 201. Europe Gabapentin Drug Revenue by Application (2021-2026) & (US$ Million) Table 202. Europe Gabapentin Drug Revenue by Application (2027-2032) & (US$ Million) Table 203. Europe Gabapentin Drug Sales by Application (2021-2026) & (W Units) Table 204. Europe Gabapentin Drug Sales by Application (2027-2032) & (W Units) Table 205. Europe Gabapentin Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 206. Europe Gabapentin Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 207. Europe Gabapentin Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 208. Europe Gabapentin Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 209. Europe Gabapentin Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 210. Europe Gabapentin Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 211. Europe Gabapentin Drug Sales by Country (2021-2026) & (W Units) Table 212. Europe Gabapentin Drug Sales by Country (2027-2032) & (W Units) Table 213. Europe Gabapentin Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 214. Europe Gabapentin Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 215. Germany Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 216. France Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 217. U.K. Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 218. Italy Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 219. Netherlands Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 220. China Gabapentin Drug Revenue by Type (2021-2026) & (US$ Million) Table 221. China Gabapentin Drug Revenue by Type (2027-2032) & (US$ Million) Table 222. China Gabapentin Drug Sales by Type (2021-2026) & (W Units) Table 223. China Gabapentin Drug Sales by Type (2027-2032) & (W Units) Table 224. China Gabapentin Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 225. China Gabapentin Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 226. China Gabapentin Drug Revenue by Application (2021-2026) & (US$ Million) Table 227. China Gabapentin Drug Revenue by Application (2027-2032) & (US$ Million) Table 228. China Gabapentin Drug Sales by Application (2021-2026) & (W Units) Table 229. China Gabapentin Drug Sales by Application (2027-2032) & (W Units) Table 230. China Gabapentin Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 231. China Gabapentin Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 232. Asia Gabapentin Drug Revenue by Type (2021-2026) & (US$ Million) Table 233. Asia Gabapentin Drug Revenue by Type (2027-2032) & (US$ Million) Table 234. Asia Gabapentin Drug Sales by Type (2021-2026) & (W Units) Table 235. Asia Gabapentin Drug Sales by Type (2027-2032) & (W Units) Table 236. Asia Gabapentin Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 237. Asia Gabapentin Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 238. Asia Gabapentin Drug Revenue by Application (2021-2026) & (US$ Million) Table 239. Asia Gabapentin Drug Revenue by Application (2027-2032) & (US$ Million) Table 240. Asia Gabapentin Drug Sales by Application (2021-2026) & (W Units) Table 241. Asia Gabapentin Drug Sales by Application (2027-2032) & (W Units) Table 242. Asia Gabapentin Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 243. Asia Gabapentin Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 244. Asia Gabapentin Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 245. Asia Gabapentin Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 246. Asia Gabapentin Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 247. Asia Gabapentin Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 248. Asia Gabapentin Drug Sales by Country (2021-2026) & (W Units) Table 249. Asia Gabapentin Drug Sales by Country (2027-2032) & (W Units) Table 250. Asia Gabapentin Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 251. Asia Gabapentin Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 252. Japan Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 253. South Korea Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 254. India Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 255. Australia Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 256. China Taiwan Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 257. Southeast Asia Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 258. SAMEA Gabapentin Drug Revenue by Type (2021-2026) & (US$ Million) Table 259. SAMEA Gabapentin Drug Revenue by Type (2027-2032) & (US$ Million) Table 260. SAMEA Gabapentin Drug Sales by Type (2021-2026) & (W Units) Table 261. SAMEA Gabapentin Drug Sales by Type (2027-2032) & (W Units) Table 262. SAMEA Gabapentin Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 263. SAMEA Gabapentin Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 264. SAMEA Gabapentin Drug Revenue by Application (2021-2026) & (US$ Million) Table 265. SAMEA Gabapentin Drug Revenue by Application (2027-2032) & (US$ Million) Table 266. SAMEA Gabapentin Drug Sales by Application (2021-2026) & (W Units) Table 267. SAMEA Gabapentin Drug Sales by Application (2027-2032) & (W Units) Table 268. SAMEA Gabapentin Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 269. SAMEA Gabapentin Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 270. SAMEA Gabapentin Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 271. SAMEA Gabapentin Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 272. SAMEA Gabapentin Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 273. SAMEA Gabapentin Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 274. SAMEA Gabapentin Drug Sales by Country (2021-2026) & (W Units) Table 275. SAMEA Gabapentin Drug Sales by Country (2027-2032) & (W Units) Table 276. SAMEA Gabapentin Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 277. SAMEA Gabapentin Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 278. Brazil Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 279. Argentina Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 280. Chile Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 281. Colombia Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 282. Peru Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 283. Saudi Arabia Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 284. Israel Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 285. UAE Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 286. Turkey Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 287. Iran Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 288. Egypt Gabapentin Drug Revenue (2021-2032) & (US$ Million) Table 289. Key Raw Materials Table 290. Raw Materials Key Suppliers Table 291. Gabapentin Drug Distributors List Table 292. Gabapentin Drug Customers List Table 293. Research Programs/Design for This Report Table 294. Authors List of This Report Table 295. Secondary Sources Table 296. Primary Sources List of Figures Figure 1. Gabapentin Drug Image Figure 2. Global Gabapentin Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gabapentin Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Capsule Image Figure 5. Oral Solution Image Figure 6. Tablet Image Figure 7. Global Gabapentin Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Gabapentin Drug Market Size Share 2021 VS 2025 VS 2032 Figure 9. Postherpetic Neuralgia in Adults Image Figure 10. Partial Onset Seizures Image Figure 11. Others Image Figure 12. Global Gabapentin Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Gabapentin Drug Revenue (2021-2032) & (US$ Million) Figure 14. Global Gabapentin Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Gabapentin Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Gabapentin Drug Revenue Market Share by Region (2021-2032) Figure 17. Global Gabapentin Drug Sales (2021-2032) & (W Units) Figure 18. Global Gabapentin Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 19. Global Gabapentin Drug Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Gabapentin Drug Sales YoY (2021-2032) & (W Units) Figure 21. Europe Gabapentin Drug Sales YoY (2021-2032) & (W Units) Figure 22. China Gabapentin Drug Sales YoY (2021-2032) & (W Units) Figure 23. Asia (Excluding China) Gabapentin Drug Sales YoY (2021-2032) & (W Units) Figure 24. South America, Middle East and Africa Gabapentin Drug Sales YoY (2021-2032) & (W Units) Figure 25. Global Gabapentin Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Gabapentin Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Gabapentin Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Gabapentin Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Gabapentin Drug Revenue Market Share by Type (2021-2032) Figure 31. Global Gabapentin Drug Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 32. Global Gabapentin Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Gabapentin Drug Sales Market Share by Type (2021-2032) Figure 34. Global Gabapentin Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Gabapentin Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Gabapentin Drug Revenue Market Share by Application (2021-2032) Figure 37. Global Gabapentin Drug Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 38. Global Gabapentin Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Gabapentin Drug Sales Market Share by Application (2021-2032) Figure 40. North America Gabapentin Drug Revenue Share by Type (2021-2032) Figure 41. North America Gabapentin Drug Sales Share by Type (2021-2032) Figure 42. North America Gabapentin Drug Revenue Share by Application (2021-2032) Figure 43. North America Gabapentin Drug Sales Share by Application (2021-2032) Figure 44. North America Gabapentin Drug Revenue Share by Country (2021-2032) Figure 45. North America Gabapentin Drug Sales Share by Country (2021-2032) Figure 46. Europe Gabapentin Drug Revenue Share by Type (2021-2032) Figure 47. Europe Gabapentin Drug Sales Share by Type (2021-2032) Figure 48. Europe Gabapentin Drug Revenue Share by Application (2021-2032) Figure 49. Europe Gabapentin Drug Sales Share by Application (2021-2032) Figure 50. Europe Gabapentin Drug Revenue Share by Country (2021-2032) Figure 51. Europe Gabapentin Drug Sales Share by Country (2021-2032) Figure 52. China Gabapentin Drug Revenue Share by Type (2021-2032) Figure 53. China Gabapentin Drug Sales Share by Type (2021-2032) Figure 54. China Gabapentin Drug Revenue Share by Application (2021-2032) Figure 55. China Gabapentin Drug Sales Share by Application (2021-2032) Figure 56. Asia Gabapentin Drug Revenue Share by Type (2021-2032) Figure 57. Asia Gabapentin Drug Sales Share by Type (2021-2032) Figure 58. Asia Gabapentin Drug Revenue Share by Application (2021-2032) Figure 59. Asia Gabapentin Drug Sales Share by Application (2021-2032) Figure 60. Asia Gabapentin Drug Revenue Share by Country (2021-2032) Figure 61. Asia Gabapentin Drug Sales Share by Country (2021-2032) Figure 62. SAMEA Gabapentin Drug Revenue Share by Type (2021-2032) Figure 63. SAMEA Gabapentin Drug Sales Share by Type (2021-2032) Figure 64. SAMEA Gabapentin Drug Revenue Share by Application (2021-2032) Figure 65. SAMEA Gabapentin Drug Sales Share by Application (2021-2032) Figure 66. SAMEA Gabapentin Drug Revenue Share by Country (2021-2032) Figure 67. SAMEA Gabapentin Drug Sales Share by Country (2021-2032) Figure 68. Gabapentin Drug Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Gabapentin Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Oral Solution
  • Tablet
Applications
  • Postherpetic Neuralgia in Adults
  • Partial Onset Seizures
  • Others
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Mylan
  • Pfizer
  • Zydus Pharmaceuticals
  • Tris Pharma
  • Taro
  • Sciegen Pharmaceuticals
  • Marksans Pharma
  • Lupin Limited
  • Jiangsu Hengrui Medicine
  • InvaGen Pharmaceuticals
  • Hi-Tech Pharmaceuticals
  • Glenmark
  • Epic Pharma
  • Depomed
  • CSPC Ouyi Pharmaceutical
  • Aurobindo Pharma
  • Apotex
  • Amneal Pharmaceuticals
  • Alkem Laboratories
  • ACI HealthCare Limited
  • Acella Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gabapentin Drug Market by Type
  3. 1.2.1 Global Gabapentin Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Capsule
  5. 1.2.3 Oral Solution
  6. 1.2.4 Tablet
  7. 1.3 Gabapentin Drug Market by Application
  8. 1.3.1 Global Gabapentin Drug Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Postherpetic Neuralgia in Adults
  10. 1.3.3 Partial Onset Seizures
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Gabapentin Drug Market Dynamics
  1. 2.1 Gabapentin Drug Industry Trends
  2. 2.2 Gabapentin Drug Industry Drivers
  3. 2.3 Gabapentin Drug Industry Opportunities and Challenges
  4. 2.4 Gabapentin Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Gabapentin Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Gabapentin Drug Revenue by Region
  3. 3.2.1 Global Gabapentin Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gabapentin Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Gabapentin Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Gabapentin Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Gabapentin Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Gabapentin Drug Sales by Region
  9. 3.4.1 Global Gabapentin Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Gabapentin Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Gabapentin Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Gabapentin Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Gabapentin Drug Revenue by Manufacturers
  2. 4.1.1 Global Gabapentin Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Gabapentin Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Gabapentin Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gabapentin Drug Sales by Manufacturers
  6. 4.2.1 Global Gabapentin Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Gabapentin Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Gabapentin Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Gabapentin Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Gabapentin Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Gabapentin Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Gabapentin Drug Manufacturers, Product Type & Application
  13. 4.7 Global Gabapentin Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Gabapentin Drug Market CR5 and HHI
  16. 4.8.2 2025 Gabapentin Drug Tier 1, Tier 2, and Tier 3
5 Gabapentin Drug Market by Type
  1. 5.1 Global Gabapentin Drug Revenue by Type
  2. 5.1.1 Global Gabapentin Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Gabapentin Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Gabapentin Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Gabapentin Drug Sales by Type
  6. 5.2.1 Global Gabapentin Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gabapentin Drug Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Gabapentin Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Gabapentin Drug Price by Type
6 Gabapentin Drug Market by Application
  1. 6.1 Global Gabapentin Drug Revenue by Application
  2. 6.1.1 Global Gabapentin Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Gabapentin Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Gabapentin Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Gabapentin Drug Sales by Application
  6. 6.2.1 Global Gabapentin Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Gabapentin Drug Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Gabapentin Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Gabapentin Drug Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Gabapentin Drug Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Sun Pharmaceutical
  8. 7.2.1 Sun Pharmaceutical Company Information
  9. 7.2.2 Sun Pharmaceutical Business Overview
  10. 7.2.3 Sun Pharmaceutical Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sun Pharmaceutical Gabapentin Drug Product Portfolio
  12. 7.2.5 Sun Pharmaceutical Recent Developments
  13. 7.3 Mylan
  14. 7.3.1 Mylan Company Information
  15. 7.3.2 Mylan Business Overview
  16. 7.3.3 Mylan Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mylan Gabapentin Drug Product Portfolio
  18. 7.3.5 Mylan Recent Developments
  19. 7.4 Pfizer
  20. 7.4.1 Pfizer Company Information
  21. 7.4.2 Pfizer Business Overview
  22. 7.4.3 Pfizer Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Gabapentin Drug Product Portfolio
  24. 7.4.5 Pfizer Recent Developments
  25. 7.5 Zydus Pharmaceuticals
  26. 7.5.1 Zydus Pharmaceuticals Company Information
  27. 7.5.2 Zydus Pharmaceuticals Business Overview
  28. 7.5.3 Zydus Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Zydus Pharmaceuticals Gabapentin Drug Product Portfolio
  30. 7.5.5 Zydus Pharmaceuticals Recent Developments
  31. 7.6 Tris Pharma
  32. 7.6.1 Tris Pharma Company Information
  33. 7.6.2 Tris Pharma Business Overview
  34. 7.6.3 Tris Pharma Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Tris Pharma Gabapentin Drug Product Portfolio
  36. 7.6.5 Tris Pharma Recent Developments
  37. 7.7 Taro
  38. 7.7.1 Taro Company Information
  39. 7.7.2 Taro Business Overview
  40. 7.7.3 Taro Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Taro Gabapentin Drug Product Portfolio
  42. 7.7.5 Taro Recent Developments
  43. 7.8 Sciegen Pharmaceuticals
  44. 7.8.1 Sciegen Pharmaceuticals Company Information
  45. 7.8.2 Sciegen Pharmaceuticals Business Overview
  46. 7.8.3 Sciegen Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sciegen Pharmaceuticals Gabapentin Drug Product Portfolio
  48. 7.8.5 Sciegen Pharmaceuticals Recent Developments
  49. 7.9 Marksans Pharma
  50. 7.9.1 Marksans Pharma Company Information
  51. 7.9.2 Marksans Pharma Business Overview
  52. 7.9.3 Marksans Pharma Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Marksans Pharma Gabapentin Drug Product Portfolio
  54. 7.9.5 Marksans Pharma Recent Developments
  55. 7.10 Lupin Limited
  56. 7.10.1 Lupin Limited Company Information
  57. 7.10.2 Lupin Limited Business Overview
  58. 7.10.3 Lupin Limited Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Lupin Limited Gabapentin Drug Product Portfolio
  60. 7.10.5 Lupin Limited Recent Developments
  61. 7.11 Jiangsu Hengrui Medicine
  62. 7.11.1 Jiangsu Hengrui Medicine Company Information
  63. 7.11.2 Jiangsu Hengrui Medicine Business Overview
  64. 7.11.3 Jiangsu Hengrui Medicine Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Jiangsu Hengrui Medicine Gabapentin Drug Product Portfolio
  66. 7.11.5 Jiangsu Hengrui Medicine Recent Developments
  67. 7.12 InvaGen Pharmaceuticals
  68. 7.12.1 InvaGen Pharmaceuticals Company Information
  69. 7.12.2 InvaGen Pharmaceuticals Business Overview
  70. 7.12.3 InvaGen Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 InvaGen Pharmaceuticals Gabapentin Drug Product Portfolio
  72. 7.12.5 InvaGen Pharmaceuticals Recent Developments
  73. 7.13 Hi-Tech Pharmaceuticals
  74. 7.13.1 Hi-Tech Pharmaceuticals Company Information
  75. 7.13.2 Hi-Tech Pharmaceuticals Business Overview
  76. 7.13.3 Hi-Tech Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Hi-Tech Pharmaceuticals Gabapentin Drug Product Portfolio
  78. 7.13.5 Hi-Tech Pharmaceuticals Recent Developments
  79. 7.14 Glenmark
  80. 7.14.1 Glenmark Company Information
  81. 7.14.2 Glenmark Business Overview
  82. 7.14.3 Glenmark Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Glenmark Gabapentin Drug Product Portfolio
  84. 7.14.5 Glenmark Recent Developments
  85. 7.15 Epic Pharma
  86. 7.15.1 Epic Pharma Company Information
  87. 7.15.2 Epic Pharma Business Overview
  88. 7.15.3 Epic Pharma Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Epic Pharma Gabapentin Drug Product Portfolio
  90. 7.15.5 Epic Pharma Recent Developments
  91. 7.16 Depomed
  92. 7.16.1 Depomed Company Information
  93. 7.16.2 Depomed Business Overview
  94. 7.16.3 Depomed Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Depomed Gabapentin Drug Product Portfolio
  96. 7.16.5 Depomed Recent Developments
  97. 7.17 CSPC Ouyi Pharmaceutical
  98. 7.17.1 CSPC Ouyi Pharmaceutical Company Information
  99. 7.17.2 CSPC Ouyi Pharmaceutical Business Overview
  100. 7.17.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 CSPC Ouyi Pharmaceutical Gabapentin Drug Product Portfolio
  102. 7.17.5 CSPC Ouyi Pharmaceutical Recent Developments
  103. 7.18 Aurobindo Pharma
  104. 7.18.1 Aurobindo Pharma Company Information
  105. 7.18.2 Aurobindo Pharma Business Overview
  106. 7.18.3 Aurobindo Pharma Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Aurobindo Pharma Gabapentin Drug Product Portfolio
  108. 7.18.5 Aurobindo Pharma Recent Developments
  109. 7.19 Apotex
  110. 7.19.1 Apotex Company Information
  111. 7.19.2 Apotex Business Overview
  112. 7.19.3 Apotex Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Apotex Gabapentin Drug Product Portfolio
  114. 7.19.5 Apotex Recent Developments
  115. 7.20 Amneal Pharmaceuticals
  116. 7.20.1 Amneal Pharmaceuticals Company Information
  117. 7.20.2 Amneal Pharmaceuticals Business Overview
  118. 7.20.3 Amneal Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Amneal Pharmaceuticals Gabapentin Drug Product Portfolio
  120. 7.20.5 Amneal Pharmaceuticals Recent Developments
  121. 7.21 Alkem Laboratories
  122. 7.21.1 Alkem Laboratories Company Information
  123. 7.21.2 Alkem Laboratories Business Overview
  124. 7.21.3 Alkem Laboratories Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Alkem Laboratories Gabapentin Drug Product Portfolio
  126. 7.21.5 Alkem Laboratories Recent Developments
  127. 7.22 ACI HealthCare Limited
  128. 7.22.1 ACI HealthCare Limited Company Information
  129. 7.22.2 ACI HealthCare Limited Business Overview
  130. 7.22.3 ACI HealthCare Limited Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 ACI HealthCare Limited Gabapentin Drug Product Portfolio
  132. 7.22.5 ACI HealthCare Limited Recent Developments
  133. 7.23 Acella Pharmaceuticals
  134. 7.23.1 Acella Pharmaceuticals Company Information
  135. 7.23.2 Acella Pharmaceuticals Business Overview
  136. 7.23.3 Acella Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Acella Pharmaceuticals Gabapentin Drug Product Portfolio
  138. 7.23.5 Acella Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Gabapentin Drug Market Size by Type
  2. 8.1.1 North America Gabapentin Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Gabapentin Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Gabapentin Drug Price by Type (2021-2032)
  5. 8.2 North America Gabapentin Drug Market Size by Application
  6. 8.2.1 North America Gabapentin Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Gabapentin Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Gabapentin Drug Price by Application (2021-2032)
  9. 8.3 North America Gabapentin Drug Market Size by Country
  10. 8.3.1 North America Gabapentin Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Gabapentin Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Gabapentin Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Gabapentin Drug Market Size by Type
  2. 9.1.1 Europe Gabapentin Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Gabapentin Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Gabapentin Drug Price by Type (2021-2032)
  5. 9.2 Europe Gabapentin Drug Market Size by Application
  6. 9.2.1 Europe Gabapentin Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Gabapentin Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Gabapentin Drug Price by Application (2021-2032)
  9. 9.3 Europe Gabapentin Drug Market Size by Country
  10. 9.3.1 Europe Gabapentin Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Gabapentin Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Gabapentin Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Gabapentin Drug Market Size by Type
  2. 10.1.1 China Gabapentin Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Gabapentin Drug Sales by Type (2021-2032)
  4. 10.1.3 China Gabapentin Drug Price by Type (2021-2032)
  5. 10.2 China Gabapentin Drug Market Size by Application
  6. 10.2.1 China Gabapentin Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Gabapentin Drug Sales by Application (2021-2032)
  8. 10.2.3 China Gabapentin Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gabapentin Drug Market Size by Type
  2. 11.1.1 Asia Gabapentin Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Gabapentin Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Gabapentin Drug Price by Type (2021-2032)
  5. 11.2 Asia Gabapentin Drug Market Size by Application
  6. 11.2.1 Asia Gabapentin Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Gabapentin Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Gabapentin Drug Price by Application (2021-2032)
  9. 11.3 Asia Gabapentin Drug Market Size by Country
  10. 11.3.1 Asia Gabapentin Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Gabapentin Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Gabapentin Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gabapentin Drug Market Size by Type
  2. 12.1.1 SAMEA Gabapentin Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Gabapentin Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Gabapentin Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Gabapentin Drug Market Size by Application
  6. 12.2.1 SAMEA Gabapentin Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Gabapentin Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Gabapentin Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Gabapentin Drug Market Size by Country
  10. 12.3.1 SAMEA Gabapentin Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Gabapentin Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Gabapentin Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Gabapentin Drug Value Chain Analysis
  2. 13.1.1 Gabapentin Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Gabapentin Drug Production Mode & Process
  6. 13.2 Gabapentin Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Gabapentin Drug Distributors
  9. 13.2.3 Gabapentin Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst